Stockchase Research Editor: Michael O'Reilly HLF is a nutritional food company, who is seeing sales benefit from the need to improve diets as the pandemic winds down. Recently reported quarterly sales were up 19% and EPS improved by 71% from year ago levels. Both beat analyst expectations and management again upgraded its guidance. Marketing is focusing on how 28 NFL draft picks have been training with their products. It trades at 19x earnings, compared to peers over 34x. We would buy this with a stop loss at $39, looking to achieve $69 -- upside potential over 39%. Yield 0% (Analysts’ price target is $69.67)

Stockchase Research Editor: Michael O'Reilly MSFT recently reported EPS growth of 45% and revenue growth of 19%. Commercial cloud revenue was up 33%. It trades at 39x earnings, compared to peers over 61x. It pays a smallish dividend, backed by a payout ratio under 40% of cash flow. It is estimated cash reserves grew almost $2 billion and are over $15 billion now. We would buy this with a stop loss of $200, looking to achieve $290 -- upside potential over 20%. Yield 0.90% (Analysts’ price target is $289.71)

Stockchase Research Editor: Michael O'Reilly With lumber prices up 300% and demand strong for renovations, it is challenging to find an entry into the space at good value. This is the sweet spot for WFG, having 60 facilities in Canada, the US, United Kingdom and Europe. Recently reported sales were up 81%. It trades at 8x earnings, compared to peers over 17x. It pays a small dividend, backed by a payout ratio of under 10% of cashflow. We would buy this with a stop loss at $60, looking to achieve $136 -- upside potential over 38%. Yield 0.82% (Analysts’ price target is $135.70)

Trades at 20x free cashflow. Growing user base. Underlevered, as they haven't monetized all that they can. Great balance sheet. Data they collect is incredibly valuable, especially for strategic advertising. No dividend. (Analysts’ price target is $384.57)

Trades at 22x free cashflow. Incredible growth in YouTube. Significant growth in advertising coming on. Leaders in search. Significant competitive advantage. New CFO has an eye on costs. Coming out of Covid will benefit. No dividend. (Analysts’ price target is $2811.06)

Rough time, as elective surgeries on hold during Covid. Good growth. Loyal users of products, good demographics. Acquisition of Wright Medical will work out well. Yield is 1.02%. (Analysts’ price target is $270.28)

Stockchase Research Editor: Michael O'Reilly IRBT is really cleaning up as it just reported a 57% increase in revenues. Direct to consumer sales were up 146% and EPS of $0.41 beat expectations by $0.62. Semi-conductor constraints were mentioned as a reason for a slight increase in costs, but this will ease soon. It trades at 18x earnings, compared to peers at over 50x. Over 95% of the shares are institutionally held, providing good staying power. We would buy this with a stop loss at $70, looking to achieve $120 -- upside potential over 28%. Yield 0% (Analysts’ price target is $119.67)

Stockchase Research Editor: Michael O'Reilly AAPL is the largest single holding of Warren Buffet. Recently reported revenues were up 54%. It is trading at 38x earnings, compared to peers at over 62x. It pays a smallish dividend backed by a payout ratio of 25% of cashflow. We would buy this with a stop loss at $100, looking to achieve $159 -- upside potential over 27%. Yield 0.69% (Analysts’ price target is $158.58)

Stockchase Research Editor: Michael O'Reilly TSEM is a producer of semiconductors -- a space much in the news for the shortage of supply. With a focus on chips for the auto manufacturing sector, they are particularly well positioned. Trading at 30x earnings, it is very competitive to its peers at over 62x. Earnings are expected to grow another 60% this year. We would buy this with a stop loss at $23, looking to achieve $38 -- upside potential over 38%. Yield 0% (Analysts’ price target is $38.25)

They operate a multi-state U.S. health network. They're building out brick and mortrar with telehealth and speciality services there. Customers typically go in for services, but insurance companies are looking at a membership model so customers pay a fee and get access to a full suite of products. SHG is growing by acquisition and organically. Strong balance sheet and they trades at a big discount to peers. Based on their guidance for next year and their peers trading at 12-15x revenues, SHG shares should be worth $3.25 or twice current prices. He really likes management which owns a lot of shares. They're planning a Nasdaq listing. (Analysts’ price target is $1.88)

They're in cybersecurity and data management. Since 2017, they've been growing by 19 acquisitions which are accretive. It trades at a huge discount to peers like CGI, at 7.5x EBITDA and should be at 12-15x. So, the stock should be 50% higher. They report after today's close. If they miss, get in. If they beat, the stock will likely run. (Analysts’ price target is $9.67)

No price target A copper producer that flies under the radar operating, operating in Chile. They get the tailings from the world's largest copper mine and then they produce copper from it. Thet spent $300 million to build this project. They're hugely leveraged to copper. They continue to process more. They guide 62 millions pounds for 2022. Anytime the copper price rises, their cash levels greatly rise. There's little research on this name, but he sees huge upside.

It is his second largest position. They are one of the few global players and they have these off-shore wind sites, which is the big frontier in this. He thinks this is a good entry point into this company. It could be a goo take-over candidate and there should be good growth as well. (Analysts’ price target is $53.12)

They are geared toward the re-opening of the economy. Quietly they are becoming an electric vehicle infrastructure company. Electric buses have a longer life than fossil fuel buses. (Analysts’ price target is $34.00)

They have massive free cash flow. They have a long history of dividend increases. It is still cheap relative to where commodity prices could go. You want to average into it. (Analysts’ price target is $47.63)